ALIROCUMAB

ALIROCUMAB was reported 25752 times

ALIROCUMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 FRACTIONAL EXHALED NITRIC OXIDE INCREASED 127 0.7095
1 SKIN PRESSURE MARK 85 0.4009
2 URTICARIA CONTACT 9 0.2500
3 ADMINISTRATION SITE INDENTATION 12 0.1935
4 PRODUCT DELIVERY MECHANISM ISSUE 608 0.1130
5 MYOGLOBIN BLOOD INCREASED 130 0.0850
6 LOW DENSITY LIPOPROTEIN DECREASED 116 0.0819
7 OBSTRUCTIVE SLEEP APNOEA SYNDROME 113 0.0775
8 APPLICATION SITE INJURY 14 0.0737
9 LOW DENSITY LIPOPROTEIN ABNORMAL 34 0.0555
10 INJECTION SITE INDENTATION 113 0.0521
11 ADMINISTRATION SITE WOUND 5 0.0505
12 ADMINISTRATION SITE BRUISE 17 0.0490
13 LOW DENSITY LIPOPROTEIN INCREASED 364 0.0470
14 BLOOD CHOLESTEROL DECREASED 85 0.0456
15 BRAIN NATRIURETIC PEPTIDE INCREASED 130 0.0421
16 PLANTAR FASCIITIS 135 0.0402
17 PRODUCT PREPARATION ISSUE 231 0.0352
18 MORPHOEA 16 0.0331
19 WRONG SCHEDULE 31 0.0325
20 DEVICE OPERATIONAL ISSUE 137 0.0318
21 LIPOPROTEIN (A) INCREASED 9 0.0275
22 DEVICE USE ISSUE 472 0.0270
23 TYPE IIA HYPERLIPIDAEMIA 6 0.0256
24 HIGH DENSITY LIPOPROTEIN INCREASED 24 0.0241
25 PRODUCT DOSE OMISSION 1363 0.0209
26 BLOOD TRIGLYCERIDES DECREASED 7 0.0208
27 INJECTION SITE HYPOAESTHESIA 27 0.0189
28 PRODUCT PREPARATION ERROR 384 0.0187
29 WAIST CIRCUMFERENCE INCREASED 19 0.0183
30 INJECTION SITE EXFOLIATION 12 0.0180
31 INJURY ASSOCIATED WITH DEVICE 357 0.0175
32 INJECTION SITE DRYNESS 14 0.0155
33 SENSATION OF FOREIGN BODY 130 0.0154
34 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 279 0.0152
35 HIGH DENSITY LIPOPROTEIN DECREASED 46 0.0138
36 INCREASED UPPER AIRWAY SECRETION 65 0.0126
37 EXOSTOSIS 114 0.0125
38 SECRETION DISCHARGE 152 0.0121
39 OBSTRUCTIVE AIRWAYS DISORDER 131 0.0118
40 INJECTION SITE BRUISING 905 0.0113
41 CARDIAC PACEMAKER REPLACEMENT 5 0.0108
42 OBSTRUCTIVE PANCREATITIS 8 0.0105
43 NECROTISING MYOSITIS 9 0.0104
44 INDURATION 18 0.0101
45 MYALGIA 1710 0.0100
46 INJECTION SITE DISCOLOURATION 124 0.0099
47 INFLUENZA LIKE ILLNESS 811 0.0098
48 AORTIC VALVE REPLACEMENT 12 0.0096
49 ADMINISTRATION SITE PAIN 11 0.0095
50 FOREIGN BODY IN THROAT 30 0.0095
51 INJECTION SITE HAEMORRHAGE 752 0.0094
52 MUSCLE DISCOMFORT 7 0.0089
53 DEVICE ISSUE 791 0.0088
54 INJECTION SITE EXTRAVASATION 108 0.0087
55 INJECTION SITE RASH 267 0.0087
56 STENT PLACEMENT 70 0.0087
57 PERIPHERAL ARTERY OCCLUSION 12 0.0085
58 INJECTION SITE MASS 310 0.0084
59 INJECTION SITE HYPERSENSITIVITY 26 0.0083
60 LIPIDS ABNORMAL 6 0.0083
61 RHINORRHOEA 536 0.0083
62 PULMONARY SEPSIS 12 0.0082
63 BLOOD TRIGLYCERIDES INCREASED 145 0.0082
64 BLOOD TRIGLYCERIDES ABNORMAL 7 0.0080
65 CREATINE KINASE INCREASED 6 0.0078
66 MUSCLE FATIGUE 33 0.0078
67 VASCULAR GRAFT 22 0.0076
68 VASCULAR OCCLUSION 16 0.0076
69 LIPIDS INCREASED 15 0.0074
70 EOSINOPHILIA 130 0.0074
71 PANCREATITIS RELAPSING 6 0.0073
72 INJECTION SITE SCAB 7 0.0073
73 BLOOD CHOLESTEROL INCREASED 330 0.0071
74 PNEUMOTHORAX 111 0.0070
75 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 323 0.0069
76 URGE INCONTINENCE 6 0.0069
77 BLOOD CHOLESTEROL ABNORMAL 31 0.0067
78 INJECTION SITE SWELLING 507 0.0066
79 RENAL TUBULAR INJURY 8 0.0066
80 MUSCLE SPASMS 1209 0.0066
81 INJECTION SITE PRURITUS 435 0.0065
82 DRUG DELIVERY SYSTEM MALFUNCTION 33 0.0064
83 NASAL DISORDER 17 0.0064
84 INJECTION SITE DISCHARGE 34 0.0063
85 CARDIAC OPERATION 54 0.0063
86 INJECTION SITE INDURATION 81 0.0062
87 ANGINA UNSTABLE 40 0.0061
88 CORONARY ARTERY DISEASE 186 0.0061
89 INJECTION RELATED REACTION 10 0.0061
90 INJECTION SITE ERYTHEMA 731 0.0059
91 INJECTION SITE WARMTH 119 0.0058
92 BLADDER DISCOMFORT 7 0.0056
93 SPINAL STENOSIS 23 0.0056
94 MUSCLE DISORDER 45 0.0056
95 INJECTION SITE DISCOMFORT 57 0.0054
96 CANCER SURGERY 5 0.0052
97 INJECTION SITE INFLAMMATION 26 0.0052
98 SINUS DISORDER 103 0.0052
99 SINUS PAIN 12 0.0051
100 ARTERIAL OCCLUSIVE DISEASE 40 0.0051
101 CATHETERISATION CARDIAC 21 0.0047
102 CAROTID ARTERY DISEASE 6 0.0047
103 HYPERCHOLESTEROLAEMIA 45 0.0047
104 BLOOD CREATINE PHOSPHOKINASE INCREASED 134 0.0047
105 CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY 5 0.0046
106 MUSCULOSKELETAL DISCOMFORT 79 0.0046
107 INJECTION SITE PAIN 1406 0.0046
108 LACK OF INJECTION SITE ROTATION 8 0.0046
109 IMPLANTABLE DEFIBRILLATOR INSERTION 6 0.0045
110 INJECTION SITE URTICARIA 111 0.0045
111 INJECTION SITE INJURY 25 0.0045
112 DYSPNOEA EXERTIONAL 167 0.0044
113 PRODUCT STORAGE ERROR 373 0.0043
114 PARANASAL SINUS DISCOMFORT 16 0.0042
115 DYSPHONIA 244 0.0042
116 VASCULAR INJURY 6 0.0042
117 INJECTION SITE VESICLES 25 0.0041
118 CAROTID ARTERY OCCLUSION 15 0.0041
119 POLYMYALGIA RHEUMATICA 13 0.0041
120 MIDDLE EAR EFFUSION 9 0.0041
121 PRURITUS GENERALISED 88 0.0041
122 ANGIOPLASTY 6 0.0040
123 UPPER-AIRWAY COUGH SYNDROME 33 0.0040
124 VIRAL UPPER RESPIRATORY TRACT INFECTION 19 0.0040
125 PARANASAL SINUS HYPERSECRETION 15 0.0039
126 INJECTION SITE SCAR 11 0.0039
127 SNEEZING 86 0.0038
128 INTENTIONAL DOSE OMISSION 109 0.0038
129 HEPATITIS E 6 0.0038
130 UNEVALUABLE EVENT 287 0.0038
131 PRODUCT SUPPLY ISSUE 27 0.0038
132 INJECTION SITE REACTION 260 0.0038
133 MUSCULOSKELETAL PAIN 197 0.0038
134 ANGIOPATHY 21 0.0037
135 ANEURYSM 18 0.0036
136 MUSCLE RUPTURE 14 0.0036
137 SINUS CONGESTION 48 0.0035
138 INFARCTION 24 0.0035
139 BRONCHOSPASM 50 0.0035
140 INJECTION SITE OEDEMA 6 0.0035
141 MILIARIA 6 0.0035
142 INCORRECT DOSE ADMINISTERED BY DEVICE 91 0.0035
143 NASAL CONGESTION 204 0.0035
144 UPPER RESPIRATORY TRACT CONGESTION 10 0.0035
145 DRUG EFFECT LESS THAN EXPECTED 51 0.0034
146 NECK SURGERY 8 0.0034
147 HYPERSENSITIVITY VASCULITIS 9 0.0034
148 DRUG DOSE OMISSION BY DEVICE 265 0.0034
149 URINARY BLADDER HAEMORRHAGE 7 0.0033
150 CORONARY ARTERY BYPASS 19 0.0033
151 NASOPHARYNGITIS 609 0.0033
152 MUSCLE TIGHTNESS 53 0.0033
153 EYE OPERATION 15 0.0033
154 PAIN IN EXTREMITY 959 0.0033
155 OROPHARYNGEAL PAIN 299 0.0032
156 THROAT CLEARING 12 0.0032
157 SINUS HEADACHE 19 0.0032
158 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 13 0.0032
159 CORONAVIRUS INFECTION 21 0.0032
160 BLADDER PAIN 10 0.0031
161 PRODUCT DOSE OMISSION ISSUE 926 0.0031
162 ANGINA PECTORIS 90 0.0031
163 DEVICE DEFECTIVE 54 0.0031
164 AORTIC VALVE DISEASE 5 0.0031
165 CARDIAC DISORDER 289 0.0031
166 LIPOMA 8 0.0031
167 URINE ODOUR ABNORMAL 18 0.0031
168 CHEST DISCOMFORT 310 0.0030
169 CARDIAC PACEMAKER INSERTION 18 0.0030
170 UNDERDOSE 219 0.0030
171 OROPHARYNGEAL DISCOMFORT 27 0.0030
172 BREAST SWELLING 8 0.0030
173 WHEEZING 176 0.0030
174 DYSLIPIDAEMIA 15 0.0030
175 MUSCLE ATROPHY 37 0.0029
176 VARICOSE VEIN 15 0.0029
177 IMMUNE-MEDIATED MYOSITIS 8 0.0029
178 MYOPATHY 25 0.0029
179 LIMB DISCOMFORT 89 0.0029
180 WALKING DISABILITY 6 0.0029
181 PHARYNGEAL SWELLING 28 0.0029
182 MUSCULAR WEAKNESS 325 0.0029
183 ALOPECIA AREATA 5 0.0028
184 INJECTION SITE IRRITATION 36 0.0028
185 RESPIRATORY SYMPTOM 8 0.0028
186 TENDON PAIN 21 0.0028
187 CORONARY ARTERY OCCLUSION 38 0.0028
188 ARTERIOSCLEROSIS 26 0.0028
189 CORONARY ARTERIAL STENT INSERTION 14 0.0028
190 HAEMORRHAGE URINARY TRACT 7 0.0027
191 COLONOSCOPY 6 0.0027
192 INFLUENZA 303 0.0027
193 BACK DISORDER 44 0.0027
194 THERAPEUTIC RESPONSE DECREASED 163 0.0027
195 COUGH 737 0.0026
196 ARTHRALGIA 1088 0.0026
197 GLYCOSYLATED HAEMOGLOBIN INCREASED 66 0.0026
198 ORAL PRURITUS 6 0.0026
199 RHINITIS 21 0.0026
200 FUNCTIONAL GASTROINTESTINAL DISORDER 9 0.0026
201 PIGMENTATION DISORDER 16 0.0026
202 LICHEN PLANUS 6 0.0026
203 AORTIC STENOSIS 9 0.0026
204 CAROTID ARTERY STENOSIS 9 0.0026
205 DISCOURAGEMENT 6 0.0026
206 ORAL FUNGAL INFECTION 7 0.0026
207 EXPOSURE VIA SKIN CONTACT 66 0.0025
208 SKIN MASS 17 0.0025
209 INTERCEPTED PRODUCT STORAGE ERROR 9 0.0025
210 GOUT 45 0.0025
211 RASH PRURITIC 135 0.0025
212 HEAD DISCOMFORT 44 0.0025
213 JOINT STIFFNESS 65 0.0025
214 DRUG ADMINISTERED AT INAPPROPRIATE SITE 26 0.0025
215 MYOCARDIAL INFARCTION 430 0.0025
216 BREAST DISORDER 5 0.0024
217 KNEE OPERATION 24 0.0024
218 MENISCUS INJURY 15 0.0024
219 RASH GENERALISED 63 0.0024
220 EXERCISE TOLERANCE DECREASED 14 0.0024
221 MOUTH SWELLING 14 0.0024
222 INJECTION SITE HAEMATOMA 35 0.0024
223 SKIN WARM 14 0.0024
224 RESPIRATORY TRACT CONGESTION 38 0.0024
225 ODYNOPHAGIA 14 0.0023
226 NECK PAIN 130 0.0023
227 CARDIAC FLUTTER 15 0.0023
228 ABNORMAL FAECES 19 0.0023
229 MUSCLE STRAIN 20 0.0023
230 BACK PAIN 536 0.0023
231 LIMB OPERATION 11 0.0023
232 PROSTATOMEGALY 9 0.0023
233 IMMOBILE 10 0.0023
234 THERAPY INTERRUPTED 163 0.0023
235 HYPOKINESIA 33 0.0023
236 PRODUCT USE ISSUE 427 0.0023
237 CONTUSION 217 0.0023
238 ARTERIOSPASM CORONARY 9 0.0022
239 FEAR OF INJECTION 16 0.0022
240 LIVER FUNCTION TEST INCREASED 48 0.0022
241 SHOULDER ARTHROPLASTY 6 0.0022
242 HIP ARTHROPLASTY 34 0.0022
243 IMMUNE SYSTEM DISORDER 29 0.0022
244 ATRIAL FIBRILLATION 213 0.0022
245 CHOKING SENSATION 12 0.0022
246 ISCHAEMIA 10 0.0022
247 BONE PAIN 127 0.0022
248 SERUM SICKNESS 6 0.0022
249 VASCULITIS 25 0.0021
250 CEREBRAL THROMBOSIS 6 0.0021
251 MEMORY IMPAIRMENT 289 0.0021
252 LYME DISEASE 7 0.0021
253 FIBROMYALGIA 51 0.0021
254 BRONCHITIS 155 0.0021
255 SKIN ATROPHY 12 0.0021
256 DRUG DOSE OMISSION 342 0.0021
257 TONGUE DISCOLOURATION 9 0.0021
258 TOOTH DISCOLOURATION 6 0.0020
259 DERMAL CYST 5 0.0020
260 SPINAL OPERATION 25 0.0020
261 CEREBRAL DISORDER 15 0.0020
262 TENDON DISORDER 13 0.0020
263 AMNESIA 128 0.0020
264 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
265 TRIGGER FINGER 8 0.0020
266 CHROMATURIA 44 0.0019
267 EAR DISCOMFORT 20 0.0019
268 GROIN PAIN 17 0.0019
269 SWOLLEN TONGUE 60 0.0019
270 SKIN TIGHTNESS 9 0.0019
271 MUSCULOSKELETAL STIFFNESS 167 0.0019
272 KNEE ARTHROPLASTY 40 0.0019
273 NON-CARDIAC CHEST PAIN 6 0.0019
274 NASAL DISCOMFORT 15 0.0019
275 TONGUE DISCOMFORT 8 0.0019
276 HEPATIC PAIN 8 0.0019
277 ALCOHOL ABUSE 5 0.0019
278 SLUGGISHNESS 19 0.0019
279 RASH VESICULAR 9 0.0019
280 GLUCOSE TOLERANCE IMPAIRED 11 0.0019
281 BURNING SENSATION 130 0.0019
282 THROAT IRRITATION 83 0.0018
283 PRODUCT STORAGE ISSUE 7 0.0018
284 INCREASED TENDENCY TO BRUISE 17 0.0018
285 HIP SURGERY 10 0.0018
286 PRURITUS 706 0.0018
287 WRIST FRACTURE 22 0.0018
288 SINUSITIS 188 0.0018
289 INJECTION SITE INFECTION 6 0.0018
290 CEREBROVASCULAR ACCIDENT 309 0.0018
291 FOOT OPERATION 9 0.0018
292 PROSTATIC DISORDER 10 0.0018
293 NEURALGIA 44 0.0018
294 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 326 0.0018
295 GAIT DISTURBANCE 344 0.0018
296 BRAIN FOG 28 0.0018
297 SKIN ODOUR ABNORMAL 7 0.0018
298 VULVOVAGINAL MYCOTIC INFECTION 7 0.0018
299 FEELING ABNORMAL 426 0.0018
300 PHARYNGITIS 22 0.0018
301 LIP SWELLING 59 0.0018
302 FURUNCLE 14 0.0018
303 URINE ABNORMALITY 8 0.0018
304 SKIN HAEMORRHAGE 26 0.0018
305 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 30 0.0017
306 MUSCULOSKELETAL CHEST PAIN 27 0.0017
307 ANURIA 15 0.0017
308 VITAMIN B12 DEFICIENCY 7 0.0017
309 FINE MOTOR SKILL DYSFUNCTION 5 0.0017
310 ROSACEA 8 0.0017
311 CATARACT 102 0.0017
312 ERYTHEMA NODOSUM 6 0.0017
313 POLLAKIURIA 71 0.0017
314 HEPATIC ENZYME INCREASED 116 0.0017
315 RENAL PAIN 18 0.0017
316 SPINAL DISORDER 16 0.0017
317 FEELING COLD 47 0.0017
318 HYPOACUSIS 72 0.0017
319 PAIN IN JAW 47 0.0017
320 CHEST PAIN 305 0.0016
321 DYSSTASIA 48 0.0016
322 BLOOD URINE PRESENT 31 0.0016
323 SKIN REACTION 23 0.0016
324 BRAIN NEOPLASM 15 0.0016
325 TENDERNESS 17 0.0016
326 THERAPEUTIC RESPONSE UNEXPECTED 73 0.0016
327 LABORATORY TEST ABNORMAL 48 0.0016
328 DEMENTIA 45 0.0016
329 HEPATIC ENZYME ABNORMAL 8 0.0016
330 TRANSIENT ISCHAEMIC ATTACK 54 0.0016
331 BLOOD BLISTER 5 0.0016
332 CHRONIC SINUSITIS 6 0.0016
333 CONDITION AGGRAVATED 486 0.0016
334 NASAL DRYNESS 10 0.0016
335 HYPERSENSITIVITY 296 0.0016
336 PARAESTHESIA ORAL 23 0.0016
337 PAIN 979 0.0016
338 SWELLING OF EYELID 10 0.0016
339 CORONARY ARTERY STENOSIS 8 0.0016
340 PERIPHERAL SWELLING 245 0.0016
341 BLEPHAROSPASM 10 0.0016
342 RASH 692 0.0016
343 SURGERY 93 0.0016
344 URTICARIA 265 0.0016
345 CARDIAC VALVE DISEASE 9 0.0016
346 DEVICE DIFFICULT TO USE 104 0.0016
347 BOWEL MOVEMENT IRREGULARITY 12 0.0016
348 DEVICE MALFUNCTION 110 0.0016
349 CACHEXIA 8 0.0016
350 SEASONAL ALLERGY 22 0.0016
351 DIVERTICULITIS 43 0.0016
352 SKIN DISCOLOURATION 71 0.0015
353 AUTOIMMUNE DISORDER 15 0.0015
354 PARALYSIS 22 0.0015
355 SWELLING FACE 100 0.0015
356 CHILLS 180 0.0015
357 ENERGY INCREASED 9 0.0015
358 BEDRIDDEN 20 0.0015
359 FEELING HOT 93 0.0015
360 LIMB INJURY 41 0.0015
361 MIDDLE INSOMNIA 28 0.0015
362 SWELLING 140 0.0015
363 PHARYNGEAL OEDEMA 23 0.0015
364 YELLOW SKIN 7 0.0015
365 TYPE 1 DIABETES MELLITUS 9 0.0015
366 INTRACRANIAL ANEURYSM 6 0.0015
367 FUNGAL SKIN INFECTION 6 0.0015
368 INCORRECT DOSE ADMINISTERED 338 0.0015
369 GRIP STRENGTH DECREASED 13 0.0015
370 DRY THROAT 15 0.0015
371 EXPIRED PRODUCT ADMINISTERED 49 0.0015
372 SARCOIDOSIS 7 0.0015
373 PERIPHERAL VENOUS DISEASE 6 0.0015
374 MALAISE 639 0.0015
375 LEG AMPUTATION 6 0.0015
376 GASTROINTESTINAL PAIN 16 0.0015
377 MYOSITIS 13 0.0014
378 MOBILITY DECREASED 104 0.0014
379 BLOOD PRESSURE INCREASED 220 0.0014
380 EXTRASYSTOLES 10 0.0014
381 ERYTHEMA 294 0.0014
382 EAR PRURITUS 5 0.0014
383 PRODUCTIVE COUGH 68 0.0014
384 SLEEP APNOEA SYNDROME 27 0.0014
385 NERVE COMPRESSION 13 0.0014
386 LETHARGY 81 0.0014
387 INTERVERTEBRAL DISC DISORDER 6 0.0014
388 SHOULDER OPERATION 6 0.0014
389 ARTHROPATHY 78 0.0014
390 HAEMATOMA 36 0.0014
391 TONGUE DISORDER 10 0.0014
392 MONOPLEGIA 6 0.0014
393 VERTIGO 84 0.0014
394 PRODUCT DISPENSING ERROR 30 0.0014
395 ABDOMINAL DISCOMFORT 230 0.0014
396 HYPERTRIGLYCERIDAEMIA 8 0.0014
397 PRODUCT TEMPERATURE EXCURSION ISSUE 7 0.0014
398 APHONIA 19 0.0014
399 CEREBRAL ISCHAEMIA 7 0.0014
400 BLINDNESS TRANSIENT 10 0.0014
401 FATIGUE 1054 0.0014
402 BLOOD GLUCOSE ABNORMAL 25 0.0014
403 WHEELCHAIR USER 6 0.0013
404 ASTHENIA 506 0.0013
405 HERNIA 26 0.0013
406 BONE DENSITY ABNORMAL 5 0.0013
407 EAR PAIN 26 0.0013
408 HIP FRACTURE 43 0.0013
409 OCULAR DISCOMFORT 15 0.0013
410 TASTE DISORDER 27 0.0013
411 DEVICE DEPLOYMENT ISSUE 17 0.0013
412 SCRATCH 14 0.0013
413 KIDNEY INFECTION 26 0.0013
414 LACRIMATION INCREASED 40 0.0013
415 SCIATICA 21 0.0013
416 BLOOD GLUCOSE INCREASED 248 0.0013
417 HEADACHE 823 0.0013
418 DIZZINESS 654 0.0013
419 DISCOMFORT 80 0.0013
420 ARTHRITIS 103 0.0013
421 BLADDER DISORDER 13 0.0013
422 BLOOD PRESSURE ABNORMAL 26 0.0013
423 FOOD POISONING 7 0.0013
424 COGNITIVE DISORDER 61 0.0013
425 DYSPNOEA 737 0.0013
426 MUSCLE TWITCHING 30 0.0013
427 TENDON RUPTURE 16 0.0013
428 THROAT TIGHTNESS 35 0.0013
429 BLOOD POTASSIUM INCREASED 21 0.0013
430 TENDONITIS 20 0.0013
431 DIARRHOEA 833 0.0013
432 GASTRITIS EROSIVE 6 0.0013
433 URINARY TRACT INFECTION 219 0.0013
434 DRUG INTOLERANCE 124 0.0013
435 BLISTER 72 0.0013
436 FLANK PAIN 12 0.0013
437 MOVEMENT DISORDER 41 0.0013
438 RASH ERYTHEMATOUS 61 0.0013
439 PRODUCT ADMINISTRATION INTERRUPTED 10 0.0013
440 INJECTION SITE NODULE 14 0.0013
441 PRODUCT DOSE OMISSION IN ERROR 36 0.0013
442 SKIN SWELLING 11 0.0013
443 VISUAL IMPAIRMENT 157 0.0013
444 COLITIS MICROSCOPIC 6 0.0013
445 JOINT INJURY 27 0.0013
446 RASH MACULAR 44 0.0013
447 HOSPITALISATION 193 0.0013
448 MACULAR DEGENERATION 15 0.0013
449 HYPOAESTHESIA 187 0.0012
450 PETECHIAE 13 0.0012
451 INSURANCE ISSUE 19 0.0012
452 GUILLAIN-BARRE SYNDROME 6 0.0012
453 NOCTURIA 15 0.0012
454 FLATULENCE 70 0.0012
455 FACIAL PAIN 11 0.0012
456 DEAFNESS 32 0.0012
457 ARTHROPOD BITE 9 0.0012
458 WALKING AID USER 8 0.0012
459 BLOOD TEST ABNORMAL 17 0.0012
460 EXTRA DOSE ADMINISTERED 49 0.0012
461 MUSCULOSKELETAL DISORDER 23 0.0012
462 SLEEP DISORDER 85 0.0012
463 HYPERHIDROSIS 155 0.0012
464 VEIN DISORDER 6 0.0012
465 PALPITATIONS 140 0.0012
466 THERAPY CESSATION 61 0.0012
467 DECREASED INTEREST 7 0.0012
468 ACUTE MYOCARDIAL INFARCTION 35 0.0012
469 WRONG PRODUCT ADMINISTERED 8 0.0012
470 BLOOD PRESSURE SYSTOLIC INCREASED 23 0.0012
471 VITAMIN D DECREASED 10 0.0012
472 NERVE INJURY 13 0.0012
473 ERECTILE DYSFUNCTION 30 0.0012
474 DYSURIA 43 0.0012
475 GAIT INABILITY 39 0.0012
476 BLOOD PRESSURE FLUCTUATION 28 0.0012
477 PERIPHERAL VASCULAR DISORDER 6 0.0012
478 ONYCHOCLASIS 8 0.0012
479 APHTHOUS ULCER 9 0.0012
480 CHAPPED LIPS 5 0.0012
481 HEART RATE IRREGULAR 26 0.0011
482 TONSILLITIS 6 0.0011
483 MULTIPLE ALLERGIES 9 0.0011
484 MASS 16 0.0011
485 PARAESTHESIA 180 0.0011
486 INCORRECT PRODUCT STORAGE 15 0.0011
487 DERMATITIS CONTACT 13 0.0011
488 GLOMERULAR FILTRATION RATE DECREASED 14 0.0011
489 CHOLECYSTECTOMY 13 0.0011
490 COLD SWEAT 20 0.0011
491 NEEDLE ISSUE 33 0.0011
492 TINNITUS 52 0.0011
493 ABDOMINAL PAIN UPPER 233 0.0011
494 CYSTITIS 36 0.0011
495 EYE HAEMORRHAGE 15 0.0011
496 GASTROINTESTINAL MOTILITY DISORDER 6 0.0011
497 ARRHYTHMIA 53 0.0011
498 THERAPY CHANGE 11 0.0011
499 MYASTHENIA GRAVIS 9 0.0011
500 UPPER LIMB FRACTURE 22 0.0011
501 SKIN LACERATION 12 0.0011
502 ASPHYXIA 9 0.0011
503 EYE SWELLING 41 0.0011
504 FAECES SOFT 8 0.0011
505 DRY MOUTH 89 0.0011
506 HYPERAESTHESIA 9 0.0011
507 DEVICE USE ERROR 38 0.0011
508 LOWER LIMB FRACTURE 21 0.0011
509 PERIPHERAL COLDNESS 15 0.0011
510 EAR DISORDER 5 0.0011
511 RETINAL DETACHMENT 10 0.0011
512 HYPERKERATOSIS 6 0.0011
513 ORAL DISCOMFORT 15 0.0011
514 ARTHRITIS INFECTIVE 5 0.0011
515 INITIAL INSOMNIA 11 0.0011
516 BURSITIS 13 0.0011
517 MACULAR OEDEMA 6 0.0011
518 POLYP 7 0.0011
519 CARDIOVASCULAR DISORDER 27 0.0011
520 ABDOMINAL DISTENSION 111 0.0011
521 FAECES DISCOLOURED 23 0.0011
522 ADVERSE REACTION 14 0.0011
523 GENERALISED ERYTHEMA 6 0.0011
524 TOOTHACHE 19 0.0010
525 EYE PRURITUS 35 0.0010
526 DEPRESSED MOOD 55 0.0010
527 BLOOD URIC ACID INCREASED 6 0.0010
528 CHOLELITHIASIS 34 0.0010
529 FREQUENT BOWEL MOVEMENTS 28 0.0010
530 LYMPHOMA 16 0.0010
531 ATRIOVENTRICULAR BLOCK 8 0.0010
532 NAIL DISORDER 9 0.0010
533 NEPHROLITHIASIS 47 0.0010
534 NIGHT SWEATS 33 0.0010
535 VIRAL INFECTION 34 0.0010
536 THINKING ABNORMAL 19 0.0010
537 GASTROINTESTINAL DISORDER 91 0.0010
538 LIGAMENT SPRAIN 10 0.0010
539 CONFUSIONAL STATE 163 0.0010
540 THIRST 18 0.0010
541 NERVOUSNESS 52 0.0010
542 BALANCE DISORDER 86 0.0010
543 SENSORY LOSS 8 0.0010
544 BLOOD PRESSURE DECREASED 66 0.0010
545 NEOPLASM MALIGNANT 66 0.0010
546 INGUINAL HERNIA 6 0.0010
547 PULMONARY CONGESTION 13 0.0010
548 BODY TEMPERATURE INCREASED 20 0.0010
549 EYE INFECTION 11 0.0010
550 UPPER RESPIRATORY TRACT INFECTION 45 0.0010
551 ILLNESS 100 0.0010
552 BENIGN PROSTATIC HYPERPLASIA 5 0.0010
553 IMPAIRED DRIVING ABILITY 11 0.0010
554 LOWER RESPIRATORY TRACT INFECTION 44 0.0010
555 MYOCARDIAL ISCHAEMIA 11 0.0010
556 PRODUCT PRESCRIBING ERROR 23 0.0010
557 MUSCLE INJURY 8 0.0010
558 SCAB 11 0.0010
559 APPENDICITIS 9 0.0010
560 INTERVERTEBRAL DISC PROTRUSION 21 0.0010
561 GASTROENTERITIS 14 0.0010
562 WEIGHT FLUCTUATION 10 0.0010
563 ORAL DISORDER 7 0.0010
564 DERMATITIS ALLERGIC 12 0.0010
565 NIGHTMARE 33 0.0010
566 GINGIVAL BLEEDING 13 0.0010
567 INFLAMMATION 49 0.0009
568 WEIGHT INCREASED 212 0.0009
569 FEELING JITTERY 18 0.0009
570 TRANSAMINASES INCREASED 21 0.0009
571 JOINT SWELLING 114 0.0009
572 RENAL DISORDER 44 0.0009
573 COVID-19 165 0.0009
574 HYPERTENSION 199 0.0009
575 FACIAL PARALYSIS 8 0.0009
576 EPISTAXIS 70 0.0009
577 RESTLESS LEGS SYNDROME 17 0.0009
578 HUNGER 13 0.0009
579 HYPOAESTHESIA ORAL 14 0.0009
580 ALANINE AMINOTRANSFERASE INCREASED 57 0.0009
581 CARPAL TUNNEL SYNDROME 13 0.0009
582 PAROSMIA 7 0.0009
583 PANCREATITIS 49 0.0009
584 BLOOD IRON DECREASED 11 0.0009
585 INSOMNIA 246 0.0009
586 AORTIC ANEURYSM 7 0.0009
587 BACK INJURY 10 0.0009
588 ACIDOSIS 7 0.0009
589 BLOOD GLUCOSE FLUCTUATION 10 0.0009
590 SKIN LESION 25 0.0009
591 HOSPICE CARE 9 0.0009
592 DISTURBANCE IN ATTENTION 49 0.0009
593 PRODUCT COMMUNICATION ISSUE 8 0.0009
594 OCULAR HYPERAEMIA 43 0.0009
595 PRESYNCOPE 22 0.0009
596 ALOPECIA 177 0.0009
597 CARDIAC FAILURE 72 0.0009
598 GALLBLADDER DISORDER 16 0.0009
599 BLOOD UREA INCREASED 15 0.0009
600 FALL 298 0.0009
601 QUALITY OF LIFE DECREASED 12 0.0009
602 BREAST MASS 6 0.0009
603 ORAL PAIN 20 0.0009
604 DIABETES MELLITUS 68 0.0009
605 ANAL INCONTINENCE 8 0.0009
606 EYE DISORDER 29 0.0009
607 SCAR 15 0.0009
608 ECCHYMOSIS 6 0.0009
609 SENSORY DISTURBANCE 14 0.0009
610 HYPERSOMNIA 25 0.0009
611 PROSTATIC SPECIFIC ANTIGEN INCREASED 12 0.0009
612 ABDOMINAL PAIN LOWER 22 0.0009
613 SKIN DISORDER 29 0.0009
614 HAIR GROWTH ABNORMAL 6 0.0009
615 FLUID RETENTION 44 0.0009
616 AUTOIMMUNE HEPATITIS 6 0.0009
617 ROAD TRAFFIC ACCIDENT 36 0.0009
618 ERYTHEMA MULTIFORME 8 0.0009
619 ROTATOR CUFF SYNDROME 11 0.0009
620 POLYURIA 7 0.0009
621 SPINAL PAIN 10 0.0009
622 NAUSEA 675 0.0009
623 SQUAMOUS CELL CARCINOMA 8 0.0008
624 BLOOD SODIUM DECREASED 16 0.0008
625 ACUTE CORONARY SYNDROME 7 0.0008
626 RESPIRATORY TRACT INFECTION 22 0.0008
627 BREAST PAIN 9 0.0008
628 FOOT FRACTURE 16 0.0008
629 SPUTUM DISCOLOURED 8 0.0008
630 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 60 0.0008
631 IMPAIRED WORK ABILITY 18 0.0008
632 HEART RATE INCREASED 83 0.0008
633 ACCIDENT 10 0.0008
634 HOT FLUSH 63 0.0008
635 SKIN EXFOLIATION 70 0.0008
636 ASPARTATE AMINOTRANSFERASE INCREASED 44 0.0008
637 ERUCTATION 16 0.0008
638 EAR INFECTION 22 0.0008
639 DIZZINESS POSTURAL 8 0.0008
640 ECZEMA 43 0.0008
641 UTERINE LEIOMYOMA 6 0.0008
642 HERPES ZOSTER 47 0.0008
643 ULCER 13 0.0008
644 ACCIDENTAL EXPOSURE TO PRODUCT 84 0.0008
645 ANAPHYLACTIC SHOCK 21 0.0008
646 BLOOD CREATININE INCREASED 53 0.0008
647 BLOOD MAGNESIUM DECREASED 7 0.0008
648 WEIGHT DECREASED 226 0.0008
649 DISABILITY 16 0.0008
650 THROMBOSIS 65 0.0008
651 HYDRONEPHROSIS 6 0.0008
652 EYE PAIN 45 0.0008
653 PYREXIA 275 0.0008
654 VISION BLURRED 109 0.0008
655 HAEMATURIA 27 0.0008
656 MICTURITION URGENCY 9 0.0008
657 INCREASED APPETITE 15 0.0008
658 POST PROCEDURAL COMPLICATION 15 0.0008
659 DYSGEUSIA 58 0.0008
660 BLINDNESS UNILATERAL 11 0.0008
661 RIB FRACTURE 16 0.0008
662 FOOD ALLERGY 6 0.0008
663 INTENTIONAL PRODUCT MISUSE 68 0.0008
664 URINARY INCONTINENCE 23 0.0008
665 GASTROENTERITIS VIRAL 14 0.0008
666 ANKLE FRACTURE 12 0.0008
667 CONCUSSION 6 0.0008
668 PRODUCT ODOUR ABNORMAL 8 0.0008
669 RASH PAPULAR 17 0.0008
670 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
671 PRODUCT DISTRIBUTION ISSUE 7 0.0008
672 TREMOR 125 0.0008
673 BLOOD GLUCOSE DECREASED 36 0.0007
674 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 36 0.0007
675 DIARRHOEA HAEMORRHAGIC 7 0.0007
676 UTERINE CANCER 6 0.0007
677 TUBULOINTERSTITIAL NEPHRITIS 14 0.0007
678 LACERATION 7 0.0007
679 LOCALISED INFECTION 18 0.0007
680 RHABDOMYOLYSIS 31 0.0007
681 PRODUCT ADMINISTRATION ERROR 15 0.0007
682 DYSPEPSIA 73 0.0007
683 DECREASED APPETITE 172 0.0007
684 LYMPHADENOPATHY 26 0.0007
685 ABDOMINAL PAIN 169 0.0007
686 MIGRAINE 69 0.0007
687 HYPOTHYROIDISM 23 0.0007
688 SYNCOPE 72 0.0007
689 FORMICATION 5 0.0007
690 VITAMIN D DEFICIENCY 7 0.0007
691 SKIN INFECTION 8 0.0007
692 VITREOUS FLOATERS 7 0.0007
693 SPEECH DISORDER 37 0.0007
694 INTRAOCULAR PRESSURE INCREASED 9 0.0007
695 RESPIRATORY DISORDER 21 0.0007
696 MENTAL IMPAIRMENT 17 0.0007
697 BLOOD POTASSIUM DECREASED 21 0.0007
698 BRAIN INJURY 7 0.0007
699 POOR QUALITY SLEEP 15 0.0007
700 APHASIA 21 0.0007
701 NEUROPATHY PERIPHERAL 66 0.0007
702 CONSTIPATION 151 0.0007
703 HYPERTHYROIDISM 10 0.0007
704 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 36 0.0007
705 EYELID OEDEMA 8 0.0007
706 ABNORMAL DREAMS 19 0.0007
707 TOOTH ABSCESS 7 0.0007
708 APATHY 10 0.0007
709 DYSPHAGIA 65 0.0007
710 GASTRIC ULCER 13 0.0007
711 HAEMOPTYSIS 19 0.0007
712 DRY EYE 34 0.0007
713 PURPURA 6 0.0007
714 LIVER DISORDER 30 0.0007
715 GLAUCOMA 13 0.0007
716 CELLULITIS 34 0.0007
717 ATAXIA 8 0.0007
718 FEELING DRUNK 5 0.0007
719 HYPERLIPIDAEMIA 8 0.0007
720 HAEMORRHOIDS 13 0.0007
721 BLOOD BILIRUBIN INCREASED 18 0.0007
722 ORAL HERPES 13 0.0007
723 POOR QUALITY PRODUCT ADMINISTERED 7 0.0007
724 HEAD INJURY 21 0.0007
725 FUNGAL INFECTION 22 0.0007
726 MOOD ALTERED 18 0.0007
727 GASTROOESOPHAGEAL REFLUX DISEASE 53 0.0007
728 HEART RATE DECREASED 23 0.0007
729 RENAL IMPAIRMENT 55 0.0007
730 IRRITABLE BOWEL SYNDROME 14 0.0007
731 OEDEMA PERIPHERAL 79 0.0006
732 PHARYNGITIS STREPTOCOCCAL 7 0.0006
733 GENERALISED OEDEMA 8 0.0006
734 PERSONALITY CHANGE 6 0.0006
735 ILL-DEFINED DISORDER 39 0.0006
736 LEUKAEMIA 6 0.0006
737 DISORIENTATION 25 0.0006
738 CARDIOGENIC SHOCK 9 0.0006
739 ATRIAL FLUTTER 5 0.0006
740 HEPATITIS 16 0.0006
741 THERAPY NON-RESPONDER 28 0.0006
742 FLUSHING 63 0.0006
743 SKIN ULCER 16 0.0006
744 FRUSTRATION TOLERANCE DECREASED 5 0.0006
745 HIATUS HERNIA 8 0.0006
746 CHOKING 12 0.0006
747 INTERNAL HAEMORRHAGE 7 0.0006
748 RENAL TUBULAR NECROSIS 6 0.0006
749 PNEUMONIA 198 0.0006
750 RETCHING 13 0.0006
751 ESCHERICHIA INFECTION 5 0.0006
752 ABASIA 15 0.0006
753 ACTIVITIES OF DAILY LIVING IMPAIRED 12 0.0006
754 PULMONARY MASS 9 0.0006
755 COLON CANCER 9 0.0006
756 POST PROCEDURAL HAEMORRHAGE 7 0.0006
757 JOINT RANGE OF MOTION DECREASED 8 0.0006
758 HEPATIC FUNCTION ABNORMAL 22 0.0006
759 CIRCULATORY COLLAPSE 10 0.0006
760 IMPAIRED GASTRIC EMPTYING 8 0.0006
761 POLYNEUROPATHY 7 0.0006
762 TOOTH DISORDER 13 0.0006
763 RASH MACULO-PAPULAR 13 0.0006
764 TEMPERATURE INTOLERANCE 6 0.0006
765 GLOSSODYNIA 13 0.0006
766 DIPLOPIA 15 0.0006
767 STAPHYLOCOCCAL INFECTION 19 0.0006
768 HAEMORRHAGE 60 0.0006
769 BLOOD CALCIUM INCREASED 5 0.0006
770 ADVERSE DRUG REACTION 51 0.0006
771 DIABETES MELLITUS INADEQUATE CONTROL 10 0.0006
772 CYST 7 0.0006
773 DIALYSIS 8 0.0006
774 GASTROINTESTINAL INFECTION 5 0.0006
775 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 113 0.0006
776 INTESTINAL OBSTRUCTION 21 0.0006
777 OEDEMA 30 0.0006
778 COMPLICATION ASSOCIATED WITH DEVICE 8 0.0006
779 GASTROINTESTINAL CARCINOMA 5 0.0006
780 DEPRESSION 124 0.0005
781 PHOTOSENSITIVITY REACTION 9 0.0005
782 NERVOUS SYSTEM DISORDER 17 0.0005
783 TOOTH FRACTURE 6 0.0005
784 RESPIRATORY DISTRESS 15 0.0005
785 FEEDING DISORDER 11 0.0005
786 RED BLOOD CELL SEDIMENTATION RATE INCREASED 6 0.0005
787 FOOT DEFORMITY 6 0.0005
788 BLINDNESS 22 0.0005
789 IMMUNODEFICIENCY 8 0.0005
790 WOUND 15 0.0005
791 IRRITABILITY 32 0.0005
792 GASTRITIS 14 0.0005
793 MITRAL VALVE INCOMPETENCE 6 0.0005
794 LIVER INJURY 13 0.0005
795 DERMATITIS 11 0.0005
796 GASTRIC DISORDER 18 0.0005
797 HYPERGLYCAEMIA 19 0.0005
798 EYE IRRITATION 30 0.0005
799 ACCIDENTAL OVERDOSE 19 0.0005
800 ORTHOSTATIC HYPOTENSION 9 0.0005
801 ACNE 39 0.0005
802 URINARY RETENTION 17 0.0005
803 TACHYCARDIA 45 0.0005
804 ASTHMA 57 0.0005
805 ISCHAEMIC STROKE 9 0.0005
806 INCORRECT ROUTE OF DRUG ADMINISTRATION 18 0.0005
807 CEREBRAL HAEMORRHAGE 18 0.0005
808 VOMITING 236 0.0005
809 HYPOGLYCAEMIA 24 0.0005
810 BONE DISORDER 9 0.0005
811 CEREBRAL INFARCTION 12 0.0005
812 RECTAL HAEMORRHAGE 21 0.0005
813 EUPHORIC MOOD 5 0.0005
814 OSTEOPOROSIS 20 0.0005
815 HEPATIC STEATOSIS 9 0.0005
816 BACTERIAL INFECTION 9 0.0005
817 TOOTH EXTRACTION 6 0.0005
818 LIVER FUNCTION TEST ABNORMAL 14 0.0005
819 ANXIETY 137 0.0005
820 HEPATIC CIRRHOSIS 9 0.0005
821 TYPE 2 DIABETES MELLITUS 16 0.0005
822 ANGIOEDEMA 21 0.0005
823 CANDIDA INFECTION 8 0.0005
824 PROTEINURIA 9 0.0005
825 PROCEDURAL PAIN 13 0.0005
826 PANIC ATTACK 17 0.0005
827 DRY SKIN 62 0.0005
828 DECREASED ACTIVITY 5 0.0005
829 STOMATITIS 28 0.0005
830 DRUG INEFFECTIVE 603 0.0005
831 THYROID DISORDER 7 0.0005
832 LOSS OF CONSCIOUSNESS 58 0.0005
833 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
834 STEVENS-JOHNSON SYNDROME 10 0.0004
835 LUNG DISORDER 22 0.0004
836 OSTEOARTHRITIS 19 0.0004
837 PANCREATITIS ACUTE 10 0.0004
838 PRODUCT USE COMPLAINT 7 0.0004
839 DYSKINESIA 18 0.0004
840 SOMNOLENCE 89 0.0004
841 LUNG NEOPLASM MALIGNANT 18 0.0004
842 AGITATION 32 0.0004
843 RESPIRATORY ARREST 12 0.0004
844 GASTRIC HAEMORRHAGE 5 0.0004
845 HYPOTENSION 86 0.0004
846 DEHYDRATION 57 0.0004
847 DEVICE OCCLUSION 6 0.0004
848 VENTRICULAR TACHYCARDIA 7 0.0004
849 PRODUCT USE IN UNAPPROVED INDICATION 105 0.0004
850 COVID-19 PNEUMONIA 5 0.0004
851 ADVERSE EVENT 39 0.0004
852 FRACTURE 8 0.0004
853 COAGULOPATHY 7 0.0004
854 IMPAIRED QUALITY OF LIFE 6 0.0004
855 HAEMATOCHEZIA 23 0.0004
856 ANAPHYLACTIC REACTION 23 0.0004
857 FACE OEDEMA 7 0.0004
858 INFECTION 60 0.0004
859 ANOSMIA 6 0.0004
860 DRUG-INDUCED LIVER INJURY 13 0.0004
861 SEPSIS 46 0.0004
862 PRODUCT QUALITY ISSUE 56 0.0004
863 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 7 0.0004
864 CARDIAC FAILURE CONGESTIVE 33 0.0004
865 METABOLIC ACIDOSIS 13 0.0004
866 SKIN BURNING SENSATION 29 0.0004
867 PALLOR 11 0.0004
868 AGEUSIA 10 0.0004
869 SPINAL FRACTURE 8 0.0004
870 SEIZURE 46 0.0004
871 PRODUCT PHYSICAL ISSUE 8 0.0004
872 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
873 MENTAL STATUS CHANGES 11 0.0004
874 BLOOD COUNT ABNORMAL 6 0.0004
875 DRUG ERUPTION 7 0.0004
876 DEVICE FAILURE 6 0.0004
877 OXYGEN SATURATION DECREASED 22 0.0004
878 DELUSION 6 0.0004
879 RED BLOOD CELL COUNT DECREASED 11 0.0004
880 PULMONARY HYPERTENSION 8 0.0004
881 CHRONIC KIDNEY DISEASE 29 0.0004
882 CONJUNCTIVITIS 7 0.0004
883 MOOD SWINGS 12 0.0004
884 CARDIAC ARREST 31 0.0004
885 OFF LABEL USE 327 0.0004
886 JAUNDICE 10 0.0004
887 SKIN CANCER 8 0.0004
888 RHEUMATOID ARTHRITIS 42 0.0004
889 RENAL FAILURE 49 0.0004
890 PRODUCT PRESCRIBING ISSUE 8 0.0004
891 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
892 HALLUCINATION 27 0.0004
893 SKIN IRRITATION 16 0.0003
894 DEATH 297 0.0003
895 LOCAL SWELLING 6 0.0003
896 HYPOXIA 12 0.0003
897 PULMONARY OEDEMA 15 0.0003
898 MOUTH ULCERATION 7 0.0003
899 OSTEOMYELITIS 6 0.0003
900 RESTLESSNESS 12 0.0003
901 DRUG DISPENSING ERROR 5 0.0003
902 PROSTATE CANCER 26 0.0003
903 INCORRECT PRODUCT ADMINISTRATION DURATION 7 0.0003
904 BLOOD ALKALINE PHOSPHATASE INCREASED 8 0.0003
905 EJECTION FRACTION DECREASED 5 0.0003
906 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
907 PHOTOPHOBIA 6 0.0003
908 APPLICATION SITE PAIN 7 0.0003
909 PULMONARY FIBROSIS 6 0.0003
910 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
911 PANCREATIC CARCINOMA 9 0.0003
912 SYSTEMIC LUPUS ERYTHEMATOSUS 11 0.0003
913 CRYING 11 0.0003
914 ACUTE KIDNEY INJURY 46 0.0003
915 ANGER 10 0.0003
916 EPILEPSY 9 0.0003
917 TREATMENT NONCOMPLIANCE 16 0.0003
918 DYSARTHRIA 11 0.0003
919 DEVICE DELIVERY SYSTEM ISSUE 8 0.0003
920 HAEMOGLOBIN DECREASED 30 0.0003
921 DELIRIUM 10 0.0003
922 BONE DENSITY DECREASED 9 0.0003
923 EATING DISORDER 6 0.0003
924 PLEURAL EFFUSION 17 0.0003
925 ABNORMAL BEHAVIOUR 11 0.0003
926 DEVICE LEAKAGE 12 0.0003
927 GENERAL PHYSICAL HEALTH DETERIORATION 32 0.0003
928 MENTAL DISORDER 12 0.0003
929 END STAGE RENAL DISEASE 5 0.0003
930 COLITIS ULCERATIVE 12 0.0003
931 PRODUCT SUBSTITUTION ISSUE 15 0.0003
932 PERICARDIAL EFFUSION 6 0.0003
933 BREAST CANCER 24 0.0003
934 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 18 0.0003
935 DISEASE RECURRENCE 12 0.0003
936 DRUG INTERACTION 40 0.0003
937 PSORIATIC ARTHROPATHY 10 0.0002
938 BRADYCARDIA 13 0.0002
939 IMPAIRED HEALING 8 0.0002
940 PNEUMONIA ASPIRATION 6 0.0002
941 CARDIO-RESPIRATORY ARREST 10 0.0002
942 COLITIS 9 0.0002
943 PSORIASIS 31 0.0002
944 PLATELET COUNT DECREASED 25 0.0002
945 HEPATIC FAILURE 7 0.0002
946 INTENTIONAL PRODUCT USE ISSUE 20 0.0002
947 EMOTIONAL DISORDER 7 0.0002
948 FEMUR FRACTURE 7 0.0002
949 THERAPEUTIC PRODUCT EFFECT DECREASED 10 0.0002
950 FEAR 6 0.0002
951 PAIN OF SKIN 6 0.0002
952 DEVICE BREAKAGE 9 0.0002
953 PULMONARY EMBOLISM 21 0.0002
954 C-REACTIVE PROTEIN INCREASED 8 0.0002
955 ANAEMIA 41 0.0002
956 INTERNATIONAL NORMALISED RATIO INCREASED 6 0.0002
957 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 7 0.0002
958 ENCEPHALOPATHY 5 0.0002
959 GASTROINTESTINAL HAEMORRHAGE 17 0.0002
960 HYPERKALAEMIA 7 0.0002
961 THROMBOCYTOPENIA 22 0.0002
962 EXPOSURE DURING PREGNANCY 12 0.0002
963 DRUG EFFECT INCOMPLETE 7 0.0002
964 SUICIDAL IDEATION 17 0.0002
965 VAGINAL HAEMORRHAGE 8 0.0002
966 LEUKOPENIA 9 0.0002
967 PLASMA CELL MYELOMA 7 0.0002
968 HYPOKALAEMIA 8 0.0002
969 INJURY 12 0.0002
970 ASCITES 5 0.0002
971 WITHDRAWAL SYNDROME 7 0.0002
972 NO ADVERSE EVENT 30 0.0002
973 RESPIRATORY FAILURE 12 0.0002
974 AGGRESSION 8 0.0002
975 WHITE BLOOD CELL COUNT DECREASED 16 0.0001
976 HYPONATRAEMIA 8 0.0001
977 DEEP VEIN THROMBOSIS 9 0.0001
978 BLADDER CANCER 8 0.0001
979 DERMATITIS ATOPIC 7 0.0001
980 EMOTIONAL DISTRESS 16 0.0001
981 PANCYTOPENIA 7 0.0001
982 DRUG EFFECT DECREASED 6 0.0001
983 TREATMENT FAILURE 9 0.0001
984 COMPLETED SUICIDE 9 0.0001
985 DISEASE PROGRESSION 12 0.0001
986 FOETAL EXPOSURE DURING PREGNANCY 6 0.0001
987 TOXICITY TO VARIOUS AGENTS 10 0.0001
988 OVERDOSE 10 0.0000
989 DRUG DEPENDENCE 6 0.0000